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“Waiting for the Courage to Die”
The Role of Live Theatre in Medical Education
by Fran Heller
In This Issu^
Coura^ to Die
Sadowsky’s
Bridge
r
Eric Kodish 
and Research 
on Children
Ends and Means?
Andrev^ Trew 
and IRBs
Director’s
Corner
I '
Newrfand Notes
am waiting for the courage to die,” says 
feisty hospital patient Joseph Parmigian, who 
has advanced cancer.
Parmigian is not a “real” patient but a character 
from a play entitled “Cold Storage” by Ronald 
Ribman, about two cancer patients, one in denial, 
the other facing certain death.
Voices of Diversity, a five year old theatre troupe, 
and the brainchild of Marvin Rosenberg, actor 
and Associate Professor of Social Work at CWRU, 
uses live theatre to explore health issues, like 
cancer and Parkinson’s disease, in diverse profes­
sional settings, including medical schools, nursing 
homes, and other community venues.
Hosted by the Department of Bioethics, nearly 
70 people attended a 30 minute excerpt from the 
play performed by ensemble members Rosen­
berg, and acclaimed Cleveland actors, Reuben 
and Dorothy Silver, Oct. 2. Audience members 
included medical students and faculty, nurses, re­
ligion and philosophy students and their teachers 
and miscellaneous others, all of whom responded 
in a great varirty of ways.
Though the play was first produced in 1977, 
many of the medical and ethical issues it raises 
still apply, including the high cost of hospital care 
and whether or not to tell patients the truth about 
their illness still apply. Another issue is “gallows” 
humor and how it is used in the seriocomic dra­
ma to illuminate and tolerate the difficult subject 
of cancer and terminal illness.
In the discussion period that followed, the idea 
of using humor in crisis situations aroused the 
reaction of a female nurse in the audience who 
movingly described how humor served a vital
purpose with a friend who had died of breast 
cancer. Paralyzed from the neck down, all 
her friend had left was the gift of laughter in 
response to an ironic card the nurse gave her 
to celebrate her 40th birthday.
The subject eliciting the most response con­
cerned lying or telling the truth to terminally ill 
patients. In the play, the seasoned Parmigian 
tells the new cancer patient, Landau, “Don’t tell 
them (the doctors) the tmth. They always lie to 
you.”
“We used to lie to patients as a policy,” noted 
Dr. Stuart Youngner, Chair of the Department 
of Bioethics, who was taught in medical 
school that the way to deal with people who 
had fatal illnesses was to lie to them. “Now 
the culture is that you don’t lie to people. You 
tell them the truth,” added the department 
head. While telling the truth is never easy or 
simple. Dr. Youngner believes that in gen­
eral, truth allows communication while lying 
denies it.
Drawing a distinction was anesthesiolo­
gist and Professor of Psychiatry, Dr. Helmut 
Cascorbi, who felt that there are times when 
telling people the truth can be the most cruel 
thing you can do. “It relieves the doctor, but 
not the patient,” he said. One must deal with 
truth in a merciful manner, added the physi­
cian, who thinks the pendulum has swung 
too far to the other side today.
Assisted suicide is another hot button topic 
the play touches upon. Parmigian tries to 
goad Landau into pushing him off the roof­
top, but in reality, it’s a charade, masking real 
fear. “I need someone to make the decision 
for me,” the character admits.
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“The play has great currency,” said Dr. Richard E. 
Christie, director of an internal medicine residency 
program at St. Vincent Charity Hospital. “These are 
issues that young medical students and nurses 
need to hear and reflect on. Humor is also a 
wonderful way to bring out these issues that are 
not always easy to raise.”
what the play demonstrated for Dr. Joseph 
Foley, Professor Emeritus and former Chair of the 
Department of Neurology, is how often it is the 
clown, like Parmigian, who masks his suffering 
with buffoonery as a cover up for real pain.
“The play has great currency,” said Dr. Richard E. 
Christie, director of an internal medicine residency 
program at St. Vincent Charity Hospital. The 
principal issue the program addressed that very 
week dealing with communication skills was what 
to do about the patient in denial. “These are issues 
that young medical students and nurses need to 
hear and reflect on. Humor is also a wonderful way 
to bring out these issues that are not always easy to 
raise.”
Kristen Stoner and Beth Summers are first year 
medical students who opted to attend because 
of their personal interest in the subject of life 
and death and ethics. Both found the play very 
engrossing. “Eor us as first year medical students,” 
added Stoner, “it raises the question that we should 
help them, but we don’t really know how.”
In the play, the cynical, wisecracking Parmigian 
advises the new cancer patient that the only 
way to get the doctors’ attention when making 
rounds is to fabricate some new symptom to 
“keep them interested in you.” Eor the future 
physicians, the challenge lies in learning how to 
deal with someone who is going to lie to you to 
be interesting, and at the same time make them 
feel that they don’t have to fake their symptoms to 
remain interesting.
and in this case, it is the humor that portrays, the 
indignity, powerlessness, and suffering that people 
go through and that’s something we in the health 
field need to understand from their perspective.” 
There is a distinct difference between theatre, 
which teaches symbolically and a training play, 
which teaches directly and concretely. “This is 
not a training play,” emphasized Rosenberg, “but 
theatre and art, and you have to bounce off it.”
Dolores L. Christie, Ph.D., Executive Director 
of the Catholic Theological Society of America, 
stressed that art speaks for itself and is much 
more educative than giving a lecture on how to 
treat patients. Eor Dr. Amasa B. Eord, Professor 
Emeritus of the Department of Epidemiology 
and Biostatistics, the presentation was a good 
illustration of how theatre is being used to deal 
with problems that people have trouble coping 
with. “As we find medicine being depersonalized 
by managed care as a business, we begin to 
realize that we’re losing the humanistic values. 
We’ve got to do something about protecting that,” 
emphasized Dr. Eord.
Fran Fleller is a Cleveland-based freelance writer.
This CWRU project is generously supported 
by: Harry K. Fox and Emma R. Fox Charitable 
Foundation, Mt. Sinai Health Care Foundation, 
Eleanor Gerson Supporting Foundation and The 
Andrews Foundation. For more information about 
this program, please call 440-995-1965, or e-mail 
drebello @adelphia. net
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Dr. Youngner firmly believes that there is a 
symbiotic relationship between the theatre arts 
and health professionals. “It so effectively portrays.
Building Bridges with Jonathan Sadowksy:
A Reprint from the CWRU Observer
It was a wise man that said, “Everything, but in 
moderation.” So while we offer you pieces on 
pediatric research ethics in the community and 
the growing problems with IRBs this issue, we 
also think some light-heartedness is in order. 
What follows is a reprint of “Building Bridges 
with Jonathan Sadowsky” from the CWRU Ob­
server by Samer Korkor, Contributing Reporter. 
Professor Sadowsky is a 1997 Ethics Fellow as 
well as an associate professor of history and ad­
viser for the College Scholars Program. Enjoy!
Samer Korkor: It seems as though over the years 
you have shown that you are a person with many 
interests because of the programs and initiatives 
you have been a part of. What exactly is it that 
stimulates your intellectual appetite?
Jonathan Sadowsky: I find that whatever creativity 
I have is enhanced by juxtaposing disparate areas 
of knowledge and experience. Sometimes learn­
ing about something very far from my areas of 
greatest knowledge helps me to see my special­
ties in new ways.
But true as that is, it’s a somewhat rationalized an­
swer. For reasons I can’t fully explain, I have for a 
long time wanted to be involved in many differ­
ent things.
SK: You are the head of the “College Scholars 
Program.” What exactly is it, other than a secret 
underground society dictating the fate of the city 
of Cleveland?
JS: I assure you that CSP’s secret reach ranges way 
beyond Cleveland. It has powerful influence as 
far away as Ashtabula.
Now that that secret is out: CSP is an undergradu­
ate program with several emphases. It is a chal­
lenging interdisciplinary undergraduate program, 
with an emphasis on student-directed learning. It 
tries to encourage social responsibility and ethical 
leadership. Classes are together for three years, 
and this gives their members the opportunity to 
constitute a more intense learning community 
than is possible in most other programs.
SK: We all need outlets. What are yours? What 
kind of hobbies do you have?
JS: I like to mn, and I’m in the early stages of 
training for my first marathon. I am not fast, but
I love to be outside mnning, and can do this for 
hours without getting bored. I love to read fiction 
and poetry, and sometimes try writing both. I 
watch the NBA and Major League Haseball, and 
still root for the Mets and Knicks, the teams I 
grew up with. My music tastes are mostly in post­
bop era jazz and classic rock; I also like “world 
music,” especially African.
SK: How do you eat Oreo cookies?
JS: You really do ask the tough questions. The 
temptation to separate is, of course, very strong. 
But then you’re left, usually, with a dry side. This 
dilemma causes too much anxiety, so I stick to 
chocolate chip cookies.
SK: If you could decide one book that every col­
lege student is required to read, what would it be?
JS: I’d really like to answer that, but I don’t think 
I can. Different students have different intel­
lectual needs. Kafka’s The Metamorphosis and 
Dostoyevsky’s Crime and Punishment were 
probably the books that did the most to inspire 
me to a life of reading when I was a teenager. A 
few years later, when my interest in history and 
politics grew, Immanuel Wallerstein’s The Modern 
World-System was formative, but it’s a little dated. 
One Hundred Years of Solitude by Gabriel Garcia 
Marquez and To the Lighthouse by Virginia Woolf 
are other favorite books. I believe there is still a 
lot to be learned from reading two authors that 
are unfashionable now, namely Sigmund Freud 
and Karl Marx, though I’ll admit that both made a 
lot of mistakes. Then again, we all do.
SK: Do you have a favorite TV show? A favorite 
film?
JS: My favorite current television show is HBO’s 
“Six Feet Under.” My all-time favorite television 
shows include “Star Trek: The Next Generation,” 
and “Get Smart.” Do you think I could get a “cone 
of silence” on e-Bay? Movie favorites include 
North by Northwest, 2001: A Space Odyssey, 
Monty Python and the Holy Grail, Annie Hall, The 
Return of the Secaucus Seven, The Tin Dmm, Do 
the Right Thing, The Usual Suspects, Fearless, The 
Secret Garden, and Being John Malkovich. I just 
recently saw Fearless again; Jeff Bridges stars as 
a plane crash survivor. It’s amazing. John Sayles 
and Agnieszka Holland are probably my favorite 
current directors. I’ll see anything they make.
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Using Children in Research Dr. Eric Kodish Explores 
and Explains
I
n December of 2002, the Cuyahoga County 
Board of Health, The City of Cleveland Depart­
ment of Health, and The City of Lakewood 
Division of Health announced that would conduct 
a door-to-door survey in Cuyahoga County over 
a two week period to determine the percentage 
of people who may have been exposed to West 
Nile virus. “West Nile virus is spread by the bite of 
an infected mosquito. Most people who become 
infected with West Nile virus will have either no 
symptoms or only mild ones. However, on rare 
occasions, West Nile virus infection can result in 
severe and sometimes fatal illnesses. In the U.S. 
in 2002, there were 4,156 cases of West Nile virus 
with 284 of those resulting in death,” according 
to the CDC website. The West Nile survey in the 
Cleveland area involved taking blood samples 
and answering some questions. While it wasn’t 
specifically stated if children would be asked to 
participate in this survey, what would change 
if they were? What is the protocol when using 
children as subjects: is the consent of parents 
enough, or should children have a say in whether 
or not they want to opt in? In the West Nile 
project, obtaining a blood sample was necessary 
- so what do you tell a child about the needle 
and pain? And afterwards, do you share in the 
information gathered with the children, whether 
or not they understand fully?
Questions such as these and many others 
were raised and debated during the CWRU 
Conversations on Children in Research and 
Policy presentation entitled “Ethics and Research 
on Children in the Community: Finding the 
Right Balance.” This one in a colloquia series 
that extends into 2003, sponsored by the 
Schubert Center for Child Development and the 
CWRU Consortium for Children, Families and 
Communities. This discussion was led by ethics 
fellow Eric D. Kodish, MD, an associate professor 
at Case Western Reserve University’s School of 
Medicine, where he holds academic appointments 
in biomedical ethics, pediatrics, and oncology and 
is director of the Rainbow Center for Pediatric 
Ethics. For this talk. Dr. Kodish drew on material 
from a paper commissioned by the National 
Academy of Sciences entitled “Finding the Right 
Balance,” as well as his own experiences working 
with children in the clinical research environment.
While the pillars of pediatric ethics reflect that 
of medical ethics (respect, beneficence [do no 
harm], justice); beneficence is by far the most
crucial principle of pediatric ethics. Dr. Kodish 
explained that the Academy of Pediatrics thinks 
about children having “inherent worth, as they 
are legacies and the future, and we should always 
to be thoughtful about how we treat children.” 
Despite this. Dr. Kodish believes that pediatric 
ethics has been left behind in the overall focus on 
bioethics.
In 1979, the face of subject research was changed 
forever by the publication of the Belmont Report. 
The report was written when the decades-long 
unethical and terrible treatment of research 
subjects came to light. The Belmont Report 
helped to map out the now well-known building 
blocks of research ethics: informed consent, 
risk/benefit assessment, and acknowledgement of 
justice.
Post-Belmont, there has been work done to 
protect subjects even more thoroughly. Dr.
Kodish calls an important piece of this “The Three 
Is:” investigator integrity, IRB (Institutional Review 
Board) approval, and informed consent. “I 
believe informed consent is the least effective way 
to protect human subjects,” he said. “The most 
effective way to ensure protection is investigator 
integrity, but this is also the hardest to enforce. 
However, seminars like these go a long way 
toward assuring investigator integrity.” Solid 
investigator integrity could also go a long way 
toward protecting important issues from political 
and bureaucratic hijacking.
There are important distinctions to make when it 
comes to research in the community and research 
in the hospital. For example, explained Dr. 
Kodish, while beneficence is always important in 
a research setting, in a community setting, maybe 
justice is even more important. By justice one 
can mean respect for the subject. “Participant 
selection is a component of this,” said Dr. Kodish. 
“Are we looking at a vulnerable population like 
the elderly, pregnant women or children? How 
does justice get played out in the selection 
process? We need to pay close attention to this 
for both potential benefits and potential risks. In 
research ethics, risk and benefit is tricky. There’s 
always risk to the subject, sure, but benefit can 
mean anything: benefit to the subject, but also to 
a drug company, to the investigator, to the health 
insurance company.”
When it comes to researching children, the usual 
rules tend to change.
How an investigator manages data, privacy, and 
the balance between, is vital when it comes to 
children. “Adults are free to make their own 
decisions (like ‘I want to benefit others’), but 
a child is vulnerable,” he explained. Even if a 
child’s parents give the OK, investigators need 
to trust, but verify, especially when money is 
being offered.” He added, “Children are not the 
property of their parents.”
While many investigators and IRBs are careful 
when it comes to children and research, some 
have forgone the study of children at all because 
of the risk associated. As a result. Dr. Kodish 
explained, “There is a Catch-22. Children have 
been understudied and overprotected.” But Dr. 
Kodish believes it doesn’t have to be that way.
One of the important keys to “keeping the 
balance” is making sure a child faces “no more 
than minimal risk” when doing school-based or 
door-to-door research. “Minimal risk” is the risk 
a child encounters in their day-to-day life, i.e., at 
school, or at the pediatrician’s office. “Keeping 
in mind the probability and magnitude of harm if 
discomfort is involved,” added Dr. Kodish.
But investigators need to be very careful about 
how they measure what that risk is. Recently,
Dr. Kodish was part of an advisory committee 
sub-group that helped to explore the inherent 
wrongness in the idea that if the day-to-day life 
of some children has more risk associated with 
it, you can subject them to more risk in research 
than you would other children. “We need a more 
aspirational model of what normal childhood 
ought to be. We should not use that condition to 
justify more exposure to more risk - especially in 
research in the community.”
How a researcher approaches a community is as 
important as the data he/she will gather. With 
research in the community, a good starting point 
is understanding — people need to be made 
aware that their participation in a community 
research project is purely their own decision; they 
can opt in or out of being used as subjects in 
research. Dr. Kodish added, “Parents and adults 
have a hard enough time understanding that they 
can choose not to participate in research, let alone 
realizing that the same understanding applies 
to their children.” Ideally, researchers and the 
community they will be studying should have an 
active, working partnership. “The community 
needs to understand all the components of the 
research,” explained Dr. Kodish, “and researchers
have an important ethical obligation to share 
the results of their research with the subjects 
who participated; or at least offer to share the 
results. And anything that a researcher can do 
to help the subjects and their families understand 
what is being done to benefit others will help in 
strengthening the partnership.” '
Kodish believes that low risk research involving 
children in the community offers an excellent 
opportunity to—not only get children involved— 
but to study the results of letting the children be 
involved. “Right now, for some projects, there 
is a push to involve children by getting their 
assent—this would be from the ages 8-14; and 
then after the age of 14, informed consent could 
be given,” said Dr. Kodish. “Assent” means an 
affirmative agreement. “Informed consent” means 
the agreement is given only after a complete 
explanation is made and understood by the 
patient/research subject. However, there are 
pitfalls to using something as arbitrary as age 
as a barometer to gauge kids’ readiness. “You 
shouldn’t generalize; kids are all different. It’s 
better to see what types of questions children ask; 
in fact, whether they are asking questions at all is 
at least one good indicator of what the children 
understand, or if they feel comfortable with the 
investigator — children are able to express a lot, if 
they feel willing,” he added.
When gathering the information that comes from 
children in the community, investigators need to 
be aware of breeches of confidentiality. “These 
can lead,” Dr. Kodish believes, “to stigmatization 
and discrimination. You can stigmatize a child 
by stigmatizing their neighborhood, ethnicity, age 
group, or gender.” Dr. Kodish explained that 
IRBs need to see a good plan in place before 
researchers begin their studies. Part of this 
means explaining things, in detail, to the people 
of the community. “To be really ethical, you do 
not want to add to the perception that there are 
unfulfilled promises,” he said. “There is a concept 
called ‘therapeutic misconception.’ It occurs 
when people in a hospital are approached to be 
involved in research and assume it is for their own 
good. Unfortunately, the concept of ‘therapeutic 
misconception’ can be translated to community 
research, too. Do people in the community think 
they are going to benefit from all sorts of research, 
and then have their expectations unfulfilled?”
Any community research, but especially in 
research involving children, demands that
continued on page 8
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A Glance at Professor Philip C. Bobbitt
The Ends and Means of a Stimulating Discussion
A
t first glance, the choice of Professor Philip 
C. Bobbitt as the keynote presenter for the 
Center for Professional Ethics’ contribu­
tion to the Provost-funded CWRU series entitled 
“America’s Role in the World” seems obvious 
merely because of his C.V. He holds an A.B. in 
Philosophy from Princeton University; a J.D. from 
the Yale Law School; a Ph.D. in Modern History 
from Oxford University, and is currently the A.W. 
Walker Centennial Chair in Law at the University 
of Texas where he has been a member of the 
faculty since 1976. But that’s only the beginning: 
he’s also served in the U.S. government under 
both parties and in all three branches, and until 
mid-June of 1999, he was the Senior Director for 
Strategic Planning at the Nation Security Council. 
Don’t forget his latest book. The Shield of Achilles. 
It has been widely acclaimed because of its depth 
and scope, as well as the seamless way it inter­
twines art, literature, politics and philosophy - all 
while talking about...war.
War is the word on everyone’s lips right now, 
just as it was on November 18, 2002, when the 
CPE held the forum Ends and Means in the War 
against Terrorism at the CWRU School of Law. 
Professor Bobbit, along with CWRU Professors 
Ken Grundy (Political Science) and Michael Scharf 
(Law), gave the large group gathered more than 
just food for thought. In the words of CPE Direc­
tor Robert Lawry, moderator of the forum, “The 
challenge of what Professor Bobbitt is talking 
about is that the world is changing and the world 
continues to change. The reason I think Professor 
Bobbitt is so important to us is because he’s trying 
to say, ‘Look, I don’t know for sure what’s going 
to happen, but the world constantly changes and 
we can’t use the same concepts and we can’t use 
the same strategy that we did yesterday to fight 
what is a new kind of problem.’”
Lately, the soft-spoken and erudite Professor Bob­
bitt has challenged quite a few preconceived no­
tions. In a book review, Fred Siegel of the Weekly 
Standard writes, “Bobbitt’s book (The Shield of 
Achilles: War, Peace and the Course of History)
has evoked a bitterly hostile response from the 
bien peasants of academia, who brand him a 
war monger.” Yet, in Bobbit’s Ends and Means 
speech to the CWRU community, he says, “I think
that cloaking policies within the mantle of war, 
although it’s something that shrewd politicians 
can do, is very unethical. And calling people 
unpatriotic [for disagreeing with the government] 
is shameful. It is tempting to conduct a ‘per­
petual war’ just so you can cloak all these things 
in patriotism while wrapping the flag around the 
other policies.” Michael Knox Beran was on the 
money when he called Bobbit, “a rare combina­
tion of philosopher and public servant.”
While neither Professor Scharf nor Professor Grun­
dy fully agreed with all of what Professor Bobbit 
had to say, they did agree that Professor Bobbit 
was “a great sparring partner” and “stimulating,” 
respectively. As well, Professor Lawry brought 
Philip Bobbit to speak at CWRU not because he 
agreed on all issues with Professor Bobbit, or 
because Professor Bobbitt was uncontroversial; it 
was because Professor Bobbit had something new 
and thought-provoking to say. In the last part of 
his keynote speech. Professor Bobbitt said, “We 
must develop rules that define what terrorism is; 
who is a terrorist; and what states can lawfully do 
to fight them. Unless we do this, it will bring our 
alliances to ruin, as we appear to rampage around 
the world, declaring our enemies to be terrorists 
and ourselves to be above the law in retaliating 
against them. We will become, in the eyes of 
others, the supreme rogue state and will have no 
moral basis on which to justify our actions and the 
simple assertion of our power. At the same time, 
we must preserve our open society by careful 
appreciation of the threat that terrorism poses to 
it and not by trying to minimize it, or to appease 
people who wish it would go away.”
Pretty stimulating....
The Ends and Means forum was co-sponsored by 
the Center for Professional Ethics, the Center for 
Public Policy and the Frederick K. Cox Interna­
tional Law Center.
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Industry-Sponsored Research — What’s Wrong?
Professor Andrew Trew Talks About IRBs, Ethics and Patients
O
n February 12, 2003 the Department of 
Bioethics at CWRU series, Conversation 
in Bioethics featured friend of the 
CPE, Professor Andrew Trew. Andrew Trew is 
a professor of bioethics, and the director of the 
Tuohy Program on Science and Religion at John 
Carroll University in Cleveland, Ohio. His talk, 
“IRBs vs. Industry: Who’s Controlling the Ethics of 
Biomedical Research?” touched on some subjects 
which are central to Professor Trew’s expertise: 
legal issues in bioethics (he holds a J.D. from the 
University of Bristol, England) and practical issues 
confronting IRBs (Institutional Review Boards).
He is the only non-institutional member presently 
holding a seat on the Cleveland Clinic’s IRB.
Independence of researchers; conflicts of interest; 
treatment of patients without adequate consent 
- these are just a few of the serious problems 
IRBs around the country have been dealing with 
now more than ever. Professor Trew believes the 
problem springs, not from how the research is 
being done, but from the sheer volume of medical 
research institutions are trying to do, ever since 
the commercial industry began sponsoring them. 
“Institutions feel pressure to acquire as many 
of these prestigious contracts as they can,” said 
Professor Trew. “There has been such increase 
in industry-sponsored research that these IRBs are 
overburdened with the ethical problems which 
have increased dramatically in the last few years.”
The Bayh-Dole Act of 1980 led to the 
commercialization of federally funded 
inventions, which led, added Professor Trew,
“to large degrees of technology transfer between 
universities and the commercial sector.” He 
believes within these partnerships lie some 
enormous benefits, as well as enormous pressures 
and many traps and temptations.
The “business” of medical research has grown 
dramatically it the last 20 years. “In terms of 
dollars, this is a huge industry, and the growth 
shows no signs of slowing down. Between 1980 
and 2000, the dollar amounts go from 1.5 billion 
in 1980, to 24.5 billion in 2000.” He added, “And 
the revenue generated from the actual outcome 
from this type of research is 130 billion dollars a 
year. In essence, you have to look at the ethics of 
healthcare in a business environment.”
Professor Trew wonders how well the patients’ 
and consumers’ watchdogs - institutional review 
boards - are able to, not only resist the pressures 
from a commercial healthcare industry, but stay 
abreast of all facets of the medical research 
going at their institutions. More importantly, 
can a balance be struck between the realities of 
this industry and the adequate protection of the 
vulnerable? “There have been deaths in healthy 
volunteers in studies. IRBs are taking a closer 
look, not just at conflict of interest, but the 
complexity of the research environment today,” 
said Professor Trew.
But are IRBs the only ones who should be 
‘taking a closer look?’ “Perhaps we need bigger 
watchdogs,” said Professor Trew. “Maybe 
we need stronger oversight by the federal 
government, including regulation of ethical 
standards. Recent legal actions have shown that 
lawyers have become another sort of watchdog 
for patients and subjects — lawyers are looking 
at challenges to the question of whether informed 
consent has been obtained, and whether conflicts 
of interest have been adequately disclosed.”
While oversight is important, there needs to be a 
way of preventing these problems from occurring 
at all. “The lack of accreditation for bioethicists 
is a problem. What the underpinning philosophy 
of bioethics is in the 21st century remains 
remarkably vague.” Traditional ideas of what 
healthcare ethics entail are now being merged 
into business and legal issues. “Now contractual 
legal considerations are overshadowing and 
dominating what used to be the individual 
relationship between doctor and patient, and 
it is threatening the nature of the Hippocratic 
ideal; a notion which is based on trust, personal 
relationships and equal treatment for rich and 
poor,” he explained.
Traditionally, IRBs have struggled to reflect 
traditional principles of bioethics. Nowadays, 
they need to be fluent in not only traditional 
medical ethics and bioethics, but the ethics of 
business, technology, law...and the list keeps 
on growing. “Members of these boards have to 
deal with unseen pressures and review complex 
studies over which they may have little expertise. 
“For example,” said Professor Trew, “in these
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days of high technology in medical institutions, 
what we ‘can do’ should not take the place of 
what we ‘ought to do.’ In regard to business and 
finances, where do you start with total financial 
disclosure — with the investigator/researcher? 
Should researchers get a payment at all? Or, 
should there be a limit to how many studies an 
investigator can work on?”
Those are not the only serious issues. In a piece 
entitled Science for Sale shown on Bill Moyers’ 
program Now, it was shown that advertisers are 
collaborating with sponsors to produce their own 
private research activities. “These activities are 
very much skewed toward the corporate agenda,” 
said Professor Trew. “Sponsors have also been 
trying, through back door activities using IRB’s 
in-house lawyers, to acquire information about 
research subjects, using the idea that they hold 
ownership over the research data.”
Professor Trew believes there are simple ways 
to help ensure that an institutional review board 
is sound, ethically. “The IRB should always be 
bending over backwards not to be a lapdog of 
the institution, but a watchdog for patients and 
subjects,” he said. “I believe the independence of 
the IRB is key — 25% of the board should be non- 
institutional, including, perhaps, an independent 
bioethicist or healthcare lawyer. In looking at the 
individual interests of each of the members: do 
they have any undue interest in the sponsoring 
companies; do they hold shares in sponsoring 
companies?”
However, change from the outside has already 
begun. In 2000, the Department of Health and 
Human Services released an interim guidance 
provision which focused on the structure 
of both the boards and the research. “This 
helped to improve awareness of commercially 
credited research and forced a greater exchange 
of information between conflict of interest 
committees and IRBs. There are now training 
courses for IRB members and investigators, and 
full disclosure of financial interest on the parts 
of all parties. All of this done to raise ethics 
standards in the institution.”
sponsor,” he said. “In regard to research, many 
people think that rather than being subjects, they 
are patients who are being treated. Sick people 
are vulnerable and enrollment in a research study 
is, many times, a last chance. People need to 
know exactly what all of this means, and where 
they stand.”
Andrew Trew was last featured in the Center for 
Professional Ethics newsletter in Summer 1999. 
The piece is called “Regulating Ethics. ” To view 
the article go here: (http://www. cwru.edu/groups/ 
cpe/cpe.html — click on Spring/Summer 1999).
Children continued from page 5
research institutions, researchers, principal 
investigators, and IRBs work together to make sure 
mistakes are not made at any step of the process. 
The Kennedy-Krieger study and subsequent case 
is a good example of what can happen when is 
there is a breakdown. “The Kennedy-Krieger case 
involved a lead study in Baltimore,” explained Dr. 
Kodish. “In the course of this study about different 
methods of lead abatement (more expensive vs. 
less expensive) in inner-city Baltimore. While the 
researchers found that some kids had elevated 
levels of lead in their systems—they never 
informed the parents. Parents sued Kennedy- 
Krieger saying they should have been told about 
these elevated lead levels.” What makes this case 
especially controversial is that it was dismissed by 
the lower court because the lawyers for Kenne­
dy-Krieger argued that “they have no obligation or 
duty to subjects because they are not patients; there 
is no duty of care to a research subject.” Dr. Kod­
ish added, “This was a big mistake! The plaintiffs 
appealed to the highest court in Maryland, and they 
issued a vicious condemnation of that approach 
saying, ‘Of course these researchers have an obliga­
tion to children, and moreover, you shouldn’t be 
doing any research on children which can poten­
tially harm them at all.’ ” Dr Kodish agreed with 
this, and added, “Perhaps the duty of care regard­
ing a researcher is different than a doctor to her 
patients, but it is a duty of care nonetheless.”
In 2001, the AAMC (Association of American 
Medical Colleges) produced a report that 
gave priority to patient welfare and asked for 
transparency of financial interests. Professor 
Trew believes that focusing on patients’ and/or 
subjects’ rights should always be the first priority. 
“Patients have a right to know whether their 
doctor has a relationship, or connection to, a
Dr. Eric Kodish is on staff at Rainbow Babies and 
Children’s Hospital. He was a fellow of the Center 
for Professional Ethics during the summer of 1996. 
He has received funding from the National Institutes 
of Health as well as the National Cancer Institute as 
Principal Investigator of a grant to study informed 
consent. In addition to compiling a growing list of 
publications in his own right, he is a peer-reviewer 
for several journals.
Director’s Corner by Robert R Lawry
The Aftermath of War
I
n my judgment, the war in Iraq was morally 
unjustified. Among other reasons, it did not 
meet the important just war principle of being 
“necessary,” a last resort, rather than a mere 
strategic choice. War brings so much death and 
destmction, intended and unintended. It must not 
be anything other than the last option of decent 
and rational people.
The war was also a violation of basic principles of 
international law. (And the moral and the legal 
here, as often is the case, are closely linked). It 
was not a legitimate act of self-defense. Neither 
the United Sates nor any other country was under 
imminent—or even remote—^threat of attack by Iraq; 
nor was the war sanctioned by the United Nations.
Finally, the war was a foreign policy and strategic 
blunder. Not only have allies been alienated, but 
enemies—including terrorists and rogue states— 
have been hardened in their hatred and/or fear of 
us. As I write (April 29, 2003), the fact that about 
a dozen would-be demonstrators in a city near 
Baghdad were reportedly killed by our soldiers is 
emblematic of the problems ahead.
Now, it would take more than a few paragraphs 
in a newsletter column to set forth all of the 
arguments that led me to the conclusions set forth 
above. I know there are honest and honorable 
people who would disagree with one or more of 
those conclusions. I would like to debate those 
who disagree, but I am not going to do so at this 
time. I judge it more important to engage now 
with the aftermath of war. We have choices to 
make in the weeks and months ahead that will 
have important and long-term implications, as the 
war itself did. However, the war is over. That 
choice was made. It cannot be undone. I want 
to examine where it is we go from here. Of 
course, the thinking and the policy decisions that 
helped to propel us into the Iraqi conflict must be 
examined and challenged anew as we move ahead; 
so there is a clear linkage of past and future in 
this discussion. Moreover, I will examine only the 
moral implications of what we might do, although 
it is not possible to disengage the moral issues from 
those that are issues of international law, or, in the 
broadest sense, strategic.
The two most prominent features of our stated
foreign policy doctrine are: unilateralism and pre­
emption. The first, unilateralism', sets the tone for 
all that follows. My understanding of the term 
amounts to this:
(1) The United States is the sole super­
power in the world; and it is the biggest and 
strongest military and economic force in the 
world.
(2) The United States will determine what 
we will do to protect our own interests and the 
interests of others, even if any of those others 
disagree with our methods or our goals.
Although (1) is undoubtedly true as a factual 
matter, when linked to (2), it is a dangerous form 
of moral arrogance. It is disrespectful of others 
in the extreme. It relies upon our military and 
economic power to push others around. It is the 
attitude of a bully. Indeed, it is the perception 
of much of the rest of the world that this is what 
the United States has become: a bully. I do 
not deny that the United Nations is an imperfect 
international institution. It is often fmstrating to 
deal with others through that institution. Yet the 
U.N. was conceived in the aftermath of WW II 
as the political instrument by which future wars 
would be curtailed or averted. Moreover, outside 
the U.N., few of our own allies have joined with 
us in the Iraqi conflict. Of course, countries like 
France posture, acting sometimes in transparently 
self-serving ways. Nevertheless, it is essential in 
this ever-shrinking world that we talk and argue, 
not just simply demand, and then act defiantly 
when others disagree. If we are tmly interested in 
winning the peace, we cannot do it alone. There 
is much uneasiness in the world over the attitude 
the United States has stmck about its occupation 
of Iraq, and the rebuilding of that country. Are 
we truly going to go it alone? Do we intend no 
continued military presence there; only assistance 
to that country to rebuild it? And do we tmly 
believe we can transform this Arab state into a 
flourishing democracy without help from others? 
Or will we treat the Iraqi people the way we 
currently treat even our allies—^with disdain if they 
disagree? This is moral arrogance merging into 
hubris—^with all the tragic consequences that the 
word has built into it since we learned it from the 
Greeks.
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All of the above would be bad enough if the issues 
were less momentous. However, the doctrine of 
preemption together with unilateralism is an ominous 
thing. We attacked Iraq preemptively. Before we 
began our siege, that country was relatively weak, 
both economically and militarily. Not only did Iraq 
not present any imminent danger to the United 
States or even any other country in the Middle East, 
it posed no real long term threat either. Inspectors 
were on the ground looking for weapons of mass 
destruction. None have yet been found, even now. 
The suggestion that Iraq had anything close to 
nuclear weaponry was dismissed by all intelligence 
sources—although the White House said otherwise 
in the course of arguing for the war. What chemical 
and biological weapons it may have had is unknown. 
If something is eventually found, is it seriously to be 
argued that they posed a threat in the foreseeable 
future to anyone else? So the basic argument 
advanced by the administration had no foundation.
There is no evidence that Saddam Hussein’s regime 
was linked to al-Qaeda or to the destruction of the 
twin towers of the World Trade Center. Again, this 
linkage was subtly but unmistakably made by the 
U.S. government. Nearly half of the U.S. population 
reportedly still believes in this linkage. All that 
has happened with Iraq was fueled by the awful 
terrorist attacks on 9/11. In that sense, the terrorists 
have begun to win their war against us. 9/11 has 
made us knee-jerk shooters in the dark with bloody 
consequences for too many.
I|10
Remember, the decision was made solely by the 
U.S.A., on evidence that was thin or non-existent 
that we should release our awesome fire-power on 
a weak country that posed no discernable threat to 
anyone. As a result, many people died, many were 
wounded, devastating destruction was wrought. 
Much of the suffering was born by innocents, of 
which I include not just Iraqi innocents, but those 
who so gallantly fought for the allied armies. Is a 
world where this kind of decision can and is made 
by one nation a world we want to be responsible for 
building? No plausible theory of self-defense or the 
defense of others can be made from such materials. 
Admittedly, Saddam Hussein was/is a very bad man, 
ruthless and hurtful to his own people. But he was 
being squeezed by the international community.
With diplomacy and patience, perhaps the rest of 
the civilized world would have taken more steps 
to effectuate regime change. We will never know. 
What we do know is that, fueled by “success” 
against a hapless nation, U.S. leaders are looking to 
do the same elsewhere. They have said so. Is there 
any doubt they mean to do so, as soon as the smoke
of this campaign settles, and we can determine 
who is next. At first, it seemed Syria might be the 
chosen foe. Now a high level administration official 
was quoted the other day as saying, “Anyone can 
go to Baghdad. Real men go to Tehran.”
Any full moral analysis takes account of motives. 
Frankly, the motives of those who are responsible 
for our foreign policy are not clear to me. No 
doubt, they are inevitably mixed. Because the 
justification for the Iraqi war is so weak, it is no 
wonder there are lots of guesses by lots of people 
as to the “real” motives of our leaders. I will not 
indulge in that guessing game. For, no matter their 
motives, their actions and policy statements lead to 
the conclusion that we embarked on an immoral 
enterprise. I have not yet mentioned the economic 
costs of this dangerous journey, and the lack of 
attention we are evidencing regarding all things 
domestic, whether it is the economy in general or 
the scandalous health care crisis in particular. I am 
now just pleading that we think hard and debate 
carefully; and engage in whatever meaningful 
political activity possible to stop the United States 
of America from becoming carelessly imperialistic. 
We are clearly on the brink.
Robert P. Lawry is the Director of the 
Center for Professional Ethics and 
a Professor of Law at Case Western 
Reserve University School of Law. LLis 
column, Director’s Corner, appears 
in each issue.
Sadowsky continued from page 3
SK: If you had to choose a time period to live in, 
when would it be and where would you live?
JS: I could live in any era, but would want to live in 
one of the biggest cities of the time. I love cities.
SK: Plain and simple: If you had the choice to be 
batman or superman, which would you be, and why?
JS: I grew up reading Marvel Comics, not DC. 
Daredevil was my favorite character, and I am 
appalled that Ben Affleck, who has shown no 
signs of being an actor, has been cast to play him 
in the movie. That said: of course Superman has 
tremendous abilities. But Batman has a cooler 
costume, and that settles it.
I
Spring, 2003 Volume 4, Number 2
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Ethics Fellows News
Ethics fellow William Deal was featured in both 
the Campus News and CWRUMagazine recently.
The CWRU Campus News reports that Professor 
Deal and Brian Ruppert will be collaborating 
on a book about medieval Japanese Buddhism 
because of the generous support of the Baker- 
Nord Center for the Humanities’ Visiting Col­
laborators’ Program.
Professor Deal, his students, and his “Ethics in 
Local Perspective” course are featured in an 
issue of the CWRU Magazine. You can view 
it here: http://www.cwru.edu/pubs/cwrumag/ 
winter2003/departments/classacts/index.shtml
Ethics fellow Tim Shuckerow and the beautiful, 
“new” art education and art studio building is 
also featured in the publication. You can view 
it here: http://www.cwru.edu/pubs/cwrumag/ 
winter2003/features/picture/index, shtml
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The Center for Professional Ethics at Case West­
ern Reseive University provides opportunities for 
smdents, faculty, administrators and prctfessionals 
to explore more fully the foundations of personal 
and professional ethics. To join, please fill out 
the membership form on the back page of this 
newsletter. This newsletter is printed four times 
yearly. All rights reseived.
Center for Professional Ethics News
The Center for Professional Ethics has finally 
updated its website! You can catch up on 
newsletters (issues from 1998 through 2003 are 
archived), read about the history of the CPE, or 
send us comments.
http:/ /www. cwru. edu/groups/cpe/cpe. html
HEC Forum on Bioethics 
Consultation in the Private Sector
The past three to four decades have witnessed 
bioethics consultation in the academy and the 
hospital setting as well as in the courts and on 
government panels. Today, the biotechnology 
industry is also calling upon bioethicists for input 
or advice. The extent to which bioethicists can 
provide consultations in the private sector and 
maintain their integrity is of concern to many in 
the field. As a result, the American Society for 
Bioethics and Humanities and the American Society 
for Law, Medicine and Ethics convened a task force 
to study the issue of bioethics consultation in the 
private sector. The task force prepared a report, 
published in the Hastings Center Report (volume 
23, number 3, May-June, 2002, pages 14-20). The 
Report addresses a number of issues relevant to 
such consultation and identifies factors bioethicists 
should consider before engaging in private sector 
consulting as well as during and after providing 
such services.
Papers are sought for a thematic issue of HEC 
Fomm on bioethics consultation in the private 
sector. Papers should offer critical commentary 
on the Task Force report and address issues of 
bioethics consultation in the private sector. Papers 
should not exceed 30 typed, double-spaced 
pages. Papers will be subject to blind peer review. 
Submissions may be submitted electronically to: 
iltisas@slu.edu
Submissions may also be sent to: 
Ana litis, Ph.D.
Center for Health Care Ethics 
Saint Louis University 
3545 Lafayette Avenue 
St. Louis MO 63104
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